Insmed legal chief sells 6,149 company shares
INSMED Inc Chief Legal Officer Michael Alexander Smith reported an open-market sale of 6,149 shares of common stock at $108.47 per share.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
INSMED Inc Chief Legal Officer Michael Alexander Smith reported an open-market sale of 6,149 shares of common stock at $108.47 per share. The transaction was made under a pre-arranged Rule 10b5-1 trading plan adopted on November 7, 2025. Following this sale, he directly holds 41,613 company shares.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 6,149 | $108.47 | $667K |
Footnotes (1)
- F1. This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 7, 2025, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
Key Figures
Key Terms
Rule 10b5-1 trading plan regulatory
open-market sale financial
Securities Exchange Act of 1934 regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did INSMED (INSM) report for Michael Alexander Smith?
Was the INSMED (INSM) insider sale made under a Rule 10b5-1 plan?
What role does Michael Alexander Smith hold at INSMED (INSM)?
AI-generated analysis. How Rhea-AI works. Not financial advice.